Meeting
2017 ASCO Annual Meeting
Simultaneous molecular alterations in solid tumors with IDH1 or IDH2 mutations.
Authors
Filip Janku
The University of Texas MD Anderson Cancer Center, Houston, TX
Filip Janku , John Frederick De Groot , Milind M. Javle , Marta Penas-Prado , Rachna T. Shroff , Rajyalakshmi Luthra , Kimberly Banks , Richard B. Lanman , Anthony Paul Conley , Russell Broaddus , Michael A. Davies , Scott Kopetz , W. K. Alfred Yung , John Heymach , Siqing Fu , Kenna Rael Shaw , Funda Meric-Bernstam
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 35, 2017 (suppl; abstr 11609)
DOI
10.1200/JCO.2017.35.15_suppl.11609
Abstract #
11609
Poster Bd #
309
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT).
First Author: Helena Verdaguer
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2016 ASCO Annual Meeting
Next generation sequencing (NGS) of primary central nervous system tumors (CNST) as part of a personalized medicine cancer research program (PMRP) to identify alterations with sensitivity to targeted inhibitors.
First Author: Tara L. Benkers
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Peri-hilar cholangiocarcinoma (phCCA): A comparative comprehensive genomic profiling study.
First Author: Parth J Sampat